5 Analysts Assess Thermo Fisher Scientific: What You Need To Know
Portfolio Pulse from Benzinga Insights
Thermo Fisher Scientific (NYSE:TMO) has been assessed by 5 analysts over the last three months, showing a mix of bullish to bearish sentiments. Recent evaluations indicate an upward trend in price targets, with an average of $606.4, marking a 12.45% increase from the previous $539.25. The company's financial performance shows a -4.93% decline in revenue growth, but it maintains strong profitability indicators such as a 14.97% net margin and an ROE of 3.54%. Analysts' actions and price target adjustments reflect a positive outlook on TMO's market performance.
April 04, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Thermo Fisher Scientific has seen a positive shift in analyst sentiment, with an average price target increase to $606.4, reflecting a 12.45% rise. Despite a recent revenue decline, strong profitability and financial health indicators suggest a positive outlook.
The increase in the average price target by analysts, coupled with Thermo Fisher's strong profitability metrics such as net margin and ROE, despite a revenue decline, suggests a positive short-term impact on TMO's stock price. Analysts' adjustments in ratings and price targets reflect optimism about the company's market performance, which is likely to influence investor sentiment positively.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100